Related Experiment Videos
Immunity and drug resistance in a mouse glioma
Abstract:
The failure of chemotherapy often results in the outgrowth of drug-resistant tumor cells, and, since chemotherapy is often combined with immunotherapy, the question arises as to whether immunity directed against the original tumor offers any protection against the drug-resistant tumor cells. To approach this problem, the immunological relationships between a mouse glioma (GL26) and two FUdR-resistant transplantable tumor sublines were studied. Immunity was induced in C57BL/6 mice with neuraminidase-altered GL26 tumor cells. Immunized mice challenged with viable GL26 tumor cells were completely protected, and no tumors grew. Immune mice, when rechallenged with cells from the two FUdR-resistant tumors, gave greater protection against one of the tumors than the other, but not as much as against the original tumor. The results indicate the drug-resistant tumor cells have some immunological properties similar to the original tumor line and that further studies such as these might be of value to the staging of chemoimmunotherapy.
Insights
Immunity against original tumors offers partial protection against drug-resistant cells. Further research can aid in staging chemoimmunotherapy for better treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Chemotherapy failure leads to drug-resistant tumors.
- Chemotherapy is often combined with immunotherapy.
- The protective role of pre-existing anti-tumor immunity against resistant cells is unclear.
Purpose of the Study:
- To investigate the immunological relationship between a mouse glioma and its drug-resistant sublines.
- To determine if immunity against the original tumor protects against resistant tumor cells.
Main Methods:
- Induced immunity in C57BL/6 mice using neuraminidase-altered GL26 glioma cells.
- Challenged immunized mice with original GL26 tumor cells and two FUdR-resistant sublines.
- Assessed tumor growth as a measure of protection.
Main Results:
- Mice immunized against GL26 were completely protected against the original tumor.
- Immune mice showed partial protection against one FUdR-resistant subline and less against the other.
- Drug-resistant tumor cells retained some immunological similarities to the parent tumor.
Conclusions:
- Pre-existing anti-tumor immunity provides some cross-protection against drug-resistant variants.
- Drug-resistant tumors may retain immunogenic properties of the original tumor.
- These findings suggest potential for immune-based strategies in chemoimmunotherapy staging.